Patients & Physicians
Translating our knowledge of cellular metabolism into medicines that improve the lives of patients.
At Imbria, our mission is to translate our understanding of cellular metabolism into medicines that improve the lives of patients with limited or inadequate treatment options.
We are currently advancing treatments that can help enhance or restore energy-related cellular functions necessary to thrive.
Imbria is focused on cardiometabolic disorders
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. It is characterized by the abnormal thickening of the heart muscle, which can lead to various complications.
Chest pain from angina can feel like a heart attack. Stable angina affects more than 4% of the adult population and leads to significant reduction in quality of life.
Heart failure is a clinical syndrome characterized by the inability of the heart to sufficiently pump blood to meet the body’s metabolic needs.